A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in ...

During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...

A study, published in Basic Research in Cardiology, demonstrates in an experimental model that the heart can be protected during anthracycline treatment using a simple, non-pharmacological technique ...

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...

Brebeuf girls' basketball coach Erin Miller did not know if she could make it through season after cancer diagnosis. She ...

Peptilogics, a surgical therapeutics company dedicated to curing and preventing devastating medical device-related infections (MDRI), has announced the enrollment of the first patient in the RETAIN ...

Fifteen-year follow-up from the S0016 trial suggests that some patients with advanced-stage follicular lymphoma may be cured with standard chemoimmunotherapy, according to Dr. Jonathan W. Friedberg, ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective anticancer drugs—a class ...